Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 31, 2022European Journal Of HaematologyOpen Access

Progressive multifocal leukoencephalopathy in the context of newer therapies in hematology and review of new treatment strategies

View Full Paper
Ask AI
Bookmark
Share

Authors

PDPanagiotis DiamantopoulosLaiko General Hospital of AthensKKKonstantinos KalopisisATAikaterini Tsatsou

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Diamantopoulos et al. (2022) studied this question.

synapsesocial.com/papers/6a796aa74c448619ca0db954https://doi.org/10.1111/ejh.13751
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Progressive multifocal leukoencephalopathy and anti‐CD20 monoclonal antibodies: What do we know after 20 years of rituximab2019 · 91 citations
  2. 2Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathy2020 · 17 citations
  3. 3Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes2017 · 168 citations
  4. 4Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy2019 · 370 citations